Source-grounded facts extracted from Cycurion, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Cycurion, Inc.: Filed Certificate of Designation for Series I Convertible Preferred Stock (effective 2026-06-03).
“We have authorized 888,888 shares of our Series I Convertible Preferred Stock, par value $0.0001 per share, with a stated value of $2.25 per share.”
Cycurion, Inc. entered into Escrow Agreement with Zions Bancorporation, National Association (Escrow Agent) and Ryan Layton (Authorized Representative) valued at Company to deposit 10% of Base Merger Consideration into escrow to secure indemnification obligation (effective 2026-06-03).
“On June 3, 2026, the Company entered into an escrow agreement (the “Escrow Agreement”) with Zions Bancorporation, National Association, as escrow agent (the “Escrow Agent”), and Ryan Layton, solely in his capacity as the authorized representative of the Company Equityholders (the “Authorized Representative”), in connection with the consummation of the transactions contemplated by the Merger Agreement.”
Cycurion, Inc. entered into Leak-Out Agreements with Holders (former equityholders of Secuvant) valued at Holders may transfer securities only during specified five fiscal quarter period, limited to 20% per (effective 2026-06-03).
“ontained in the Leak-Out Agreements (as defined below). In addition, the Lock-Up Agreements include a price-based acceleration provision,”
Cycurion, Inc. entered into Lock-Up Agreements with Holders (former equityholders of Secuvant) valued at Holders agreed not to transfer preferred stock or common shares issuable upon conversion for six mon (effective 2026-06-03).
“ock-up agreements (the “Lock-Up Agreements”) with the Holders. Pursuant to the Lock-Up Agreements, the Holders agreed that,”
Cycurion, Inc. entered into Registration Rights Agreement with Secuvant, LLC and the former equityholders of Secuvant valued at Company agreed to file registration statement covering resale of common shares issuable upon convers (effective 2026-06-03).
“On June 3, 2026, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with Secuvant and the former equityholders of Secuvant (the “Holders”) in connection with the consummation of the transactions contemplated by that certain Merger Agreement.”
Cycurion, Inc. entered into Merger Agreement with Secuvant, LLC valued at Merger of Merger Sub with and into Secuvant, with Secuvant surviving as wholly owned subsidiary (effective 2026-05-21).
“On May 21, 2026 (the “Execution Date”), Cycurion, Inc. (the “Company”) entered into that certain merger agreement (the “Merger Agreement”) with Cycurion Merger Sub, LLC, a wholly owned subsidiary (“Merger Sub”), and Secuvant, LLC (“Secuvant”).”
Cycurion, Inc. issued 947.25 shares of preferred stock to Obsidian Associates, LLC for stated value of $1,000 per share.
“947.25 shares of the Company’s Series H Convertible Preferred Stock, with each share having a stated value of $1,000”
Cycurion, Inc. issued convertible note to Obsidian Associates, LLC for $1,083,003.41 of principal and accrued non-default interest.
“approximately $1,083,003.41 of principal and accrued non-default interest owed under certain existing notes was exchanged for a new convertible promissory note”
Cycurion, Inc. issued 952.7 shares of preferred stock to M2B Funding Corp. for stated value of approximately $952,695.73.
“issued 952.7 shares of Series H Convertible Preferred Stock with an aggregate stated value of approximately $952,695.73”
Cycurion, Inc. issued convertible note to M2B Funding Corp. for principal amount of $1,326,748.31.
“exchanged outstanding promissory notes for a new convertible promissory note, attached as Exhibit 10.4, in the principal amount of $1,326,748.31”
Cycurion, Inc. issued convertible note to IQ Financial, Inc. for $517,604.40 of outstanding obligations.
“approximately $517,604.40 of outstanding obligations, consisting of principal and accrued interest, was exchanged for a new convertible promissory note”
Cycurion, Inc.: Authorized Series H Convertible Preferred Stock and filed Certificate of Designation with the State of Delaware on May 29, 2026 (effective 2026-05-29).
“The foregoing summary of the terms, rights and preferences of the Series I Convertible Preferred Stock, filed with the State of Delaware on May 29, 2026, is qualified in its entirety by reference to the text of the Series H Convertible Preferred Stock Certificate of Designation, which is filed hereto as Exhibit 3.1 and is incorporated herein by reference.”
Cycurion, Inc. entered into Exchange and Restructuring Agreement with Obsidian Associates, LLC valued at $1,083,003.41 principal exchanged for new note plus 947.25 shares Series H Preferred Stock ($947,250 (effective 2026-06-01).
“On June 1, 2026, the Company entered into an Exchange and Restructuring Agreement with Obsidian, attached as Exhibit 10.5. Pursuant to that agreement, approximately $1,083,003.41 of principal and accrued non-default interest owed under certain existing notes was exchanged for a new convertible promissory note issued by the Company, attached as Exhibit 10.6.”
Cycurion, Inc. entered into Exchange Agreement with M2B Funding Corp. valued at $1,326,748.31 principal note plus 952.7 shares Series H Preferred Stock ($952,695.73) (effective 2026-06-01).
“On June 1, 2026, the Company entered into an Exchange Agreement with M2B, attached as Exhibit 10.3. Pursuant to this agreement, the Company exchanged outstanding promissory notes for a new convertible promissory note, attached as Exhibit 10.4, in the principal amount of $1,326,748.31 and issued 952.7 shares of Series H Convertible Preferred Stock with an aggregate stated value of approximately $952,695.73 in satisfaction of default-related amounts.”
Cycurion, Inc. entered into Exchange and Restructuring Agreement with IQ Financial, Inc. valued at $517,604.40 exchanged for new convertible promissory note (effective 2026-06-01).
“On June 1, 2026, the Company entered into an Exchange and Restructuring Agreement with IQ Financial, attached as Exhibit 10.1. Under this agreement, approximately $517,604.40 of outstanding obligations, consisting of principal and accrued interest, was exchanged for a new convertible promissory note, attached as Exhibit 10.2.”
Ana Garcia was appointed as Chief Financial Officer at Cycurion, Inc..
“the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.”
Alvin McCoy III departed as Chief Financial Officer at Cycurion, Inc..
“Cycurion, Inc. (the “Company”) announced that Alvin McCoy III, the Company’s Chief Financial Officer, will step down from his position effective May 31, 2026.”
Cycurion, Inc. entered into Merger Agreement with Secuvant, LLC valued at approximately $2,875,000 (effective 2026-05-21).
“On May 21, 2026 (the “Execution Date”), Cycurion, Inc. (the “Company” or “Purchaser”) entered into that certain merger agreement (the “Merger Agreement”) with Cycurion Merger Sub, LLC, a wholly owned subsidiary (“Merger Sub”), and Secuvant, LLC (the “Target”).”
Cycurion, Inc. entered into Agreement and Plan of Merger with Halo Privacy, Inc. and havenX, Inc. (effective 2026-05-07).
“On May 7, 2026, Cycurion, Inc., a Delaware corporation (“Parent”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Cycurion Merger Sub-Halo, Inc. (“Merger Sub-Halo”), Cycurion Merger Sub-havenX, Inc. (“Merger Sub-havenX”), Halo Privacy, Inc., a Delaware corporation (“Halo”), havenX, Inc., a Wyoming corporation (“havenX”), and Shareholder Representative Services LLC, solely in its capacity as the Company Group Equityholder Representative (the “Equityholder Representative”).”
Irving Minnaker resigned as Director at Cycurion, Inc..
“On April 13, 2026, Irving Minnaker resigned from the Board of Directors (the "Board") of Cycurion, Inc. (the "Company") and from any and all offices that he holds with the Company, effective as from February 14, 2026.”
Cycurion, Inc. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners valued at a cash fee equal to 10.0% of the aggregate gross proceeds raised in the Offering and a cash fee of $ (effective 2025-12-04).
“Pursuant to a placement agent agreement (the “Placement Agent Agreement”) between the Placement Agent and the Company, dated December 4, 2025, the Company agreed to pay the Placement Agent a cash fee equal to 10.0% of the aggregate gross proceeds raised in the Offering and a cash fee of $500,000, and to reimburse the Placement Agent for certain reasonable, documented, and accountable expenses, including legal fees, of $60,000 in the aggregate.”
Cycurion, Inc. entered into Purchase Agreement with a single institutional accredited investor valued at approximately $6 million (effective 2025-12-04).
“On December 4, 2025, Cycurion, Inc. (the “Company”) and a single institutional accredited investor (the “Purchaser”) entered into a securities purchase agreement (the “Purchase Agreement”), pursuant to which the Company agreed to sell to the Purchaser an aggregate of 1,657,460 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), or pre-funded warrants exercisable for $0.0001 per share in lieu thereof (the “Pre-Funded Warrants”), and accompanying common warrants to purchase up to 3,314,920 shares of Common Stock (the “Warrants”) in a private placement (the “Offering”), for gross proceeds of approximately $6 million, before deducting the placement agent’s fees and other estimated offering expenses.”
Cycurion, Inc. issued pre-funded warrants exercisable for $0.0001 per share in lieu thereof of warrant to a single institutional accredited investor for $3.62 per Pre-Funded Warrant.
“$6 million, before deducting the placement agent’s fees and other estimated offering expenses. The purchase price per Share (or Pre-Funded Warrant in lieu thereof) is $3.62. The Warrants will be exercisable immediately following receipt of stockholder approval for the issuance of the Warrants and the shares of Common Stock underlying the Warrants”
Cycurion, Inc. issued warrants to purchase up to 3,314,920 shares of Common Stock of warrant to a single institutional accredited investor for exercise price of $3.62 per share.
“$6 million, before deducting the placement agent’s fees and other estimated offering expenses. The purchase price per Share (or Pre-Funded Warrant in lieu thereof) is $3.62. The Warrants will be exercisable immediately following receipt of stockholder approval for the issuance of the Warrants and the shares of Common Stock underlying the Warrants”
Cycurion, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5450(a)(1)).
“November 11, 2025, the Company announced that it received a letter Nasdaq stating that Nasdaq has determined that the Company has regained compliance with Nasdaq’s Bid Price Rule requirement under Listing Rule 5450(a)(1). The Company is now in compliance with Nasdaq Global Market’s listing requirements. Additionally, Nasdaq confirmed that the previously scheduled hearing before the Nasdaq Hearings Panel on November 20, 2025 has been canceled. The Company’s securities will continue to be listed and traded on The Nasdaq Stock Market without interruption.”
Cycurion, Inc.: Second Amendment to the Second Amended and Restated Certificate of Incorporation filed to effect a 1-for-30 reverse stock split (effective 2025-10-27).
“The Company effected the Reverse Stock Split by filing the Second Amendment to the Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware.”
Cycurion, Inc.: Filed a second amendment to the Second Amended and Restated Certificate of Incorporation to effect a 1-for-30 reverse stock split (effective 2025-10-27).
“On October 24, 2025, Cycurion, Inc., a Delaware corporation (the “ Company ”), filed the second amendment (the “ Amendment ”) to its Second Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to implement a 1-for-30 reverse stock split of the Company’s issued and outstanding shares of common stock, par value US$0.0001 per share, which will become effective with the commencement of business on October 27, 2025”
Cycurion, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
“on April 15, 2025, the Staff notified the Company on April 9, 2025 that, for the prior 30 consecutive business days, the closing bid price of the Company’s common stock had been below the minimum of $1.00 per share required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The notification letter stated that the Company would be afforded 180 calendar days, or until October 6, 2025, to regain compliance. The Company has not regained compliance with the Bid Price Rule, and the listed security is now subject to delisting from The Nasdaq”
Cycurion, Inc.: Company increased authorized common stock from 100,000,000 to 300,000,000 shares and authorized reverse stock splits at ratios from 3:1 to 75:1 (aggregate not more than 250:1), approved by written consent of majority stockholders (effective 2025-09-29).
“The Charter Amendment increases the number of authorized shares of common stock of the Company from 100,000,000 to 300,000,000 shares of common stock and allows the Company to effect reverse stock splits of the Company’s shares of common stock.”
Cycurion, Inc.: Amended and restated bylaws to conform to certificate of incorporation and DGCL regarding election of directors (effective 2025-08-28).
“On August 28, 2025, the Board of Directors of Cycurion, Inc. (the “Company”) amended and restated the Company’s Amended and Restated Bylaws (the “Second Amended and Restated Bylaws”), effective immediately, to conform them to the provisions in the Company’s Second Amended and Restated Certificate of Incorporation and certain provisions of the Delaware General Corporation Law with respect to the election of directors.”
Cycurion, Inc.: Filed Certificate of Designation for Series G Convertible Preferred Stock establishing terms, rights, and preferences (effective 2025-08-11).
“The foregoing summary of the terms, rights and preferences of the Series G Convertible Preferred Stock, filed with the State of Delaware on August 11, 2025, is qualified in its entirety by reference to the text of the Series G Convertible Preferred Stock Certificate of Designation, which is filed hereto as Exhibit 3.1, and is incorporated herein by reference.”
Cycurion, Inc.: Filed Certificate of Designation for Series E Convertible Preferred Stock and Series F Convertible Preferred Stock with the State of Delaware on August 5, 2025 (effective 2025-08-05).
“The foregoing summary of the terms, rights and preferences of the Series E Convertible Preferred Stock and Series F Convertible Preferred Stock, each filed with the State of Delaware on August 5, 2025, is qualified in its entirety by reference to the text of the Series E Convertible Preferred Stock Certificate of Designation and Series F Convertible Preferred Stock Certificate of Designation”
Cycurion, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5810(b), 5250(c)(1)).
“May 22, 2025, Cycurion, Inc. (the “Company”) received written notice (the “Nasdaq Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Form 10-Q”), which may serve as an additional basis for the delisting of the Company’s securities from Nasdaq. The Company previously filed a Form 12b-25 with the U.S. Securities and Exchange Commission on May 15, 2025, disclosing that it was unable to file the Form 10-Q (the “Delinquent Filing”) within the prescribed time period witho”
Cycurion, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).
“April 11, 2025, the Company received two letters from the Nasdaq, each addressing a separate compliance deficiency under the Rules. The first letter notified of the deficiency with regard to Rule 5450(b)(2)(A) (the “Second Nasdaq Notice”), which requires a company, whose securities are listed on The Nasdaq Global Market under the “Market Value Standard”, to maintain a minimum Market Value of Listed Securities (an “MVLS”) of $50,000,000. The deficiency was caused by the Company’s MVLS having been below the minimum level for the prior 30 consecutive business days. Under Nasdaq Listing Rule 5810(”
Cycurion, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).
“y’s security is at least $1.00 for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and this matter will be closed. In the event the Company does not regain compliance with the Rule, the Company may be eligible for additional time under Listing Rule 5810(c)(3)(A)(ii). The Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency”
Cycurion, Inc.: Ceased to be a shell company as a result of the Business Combination.
“As a result of the Business Combination, the Company ceased to be a shell company.”
Cycurion, Inc.: Adopted a new code of conduct (that serves as code of ethics) effective upon the Closing Date.
“Effective upon the Closing Date, in connection with the completion of the Business Combination, the Board adopted a new code of conduct, which is applicable to all of the Company’s directors, officers, and employees”
Cycurion, Inc.: Adopted amended and restated bylaws via A&R Bylaws, effective as of the Closing Date.
“the Company adopted amended restated bylaws pursuant to an Amended and Restated Bylaws (the “A&R Bylaws”).”
Cycurion, Inc.: Amended and restated certificate of incorporation via Second A&R Certificate of Incorporation, effective as of the Closing Date.
“In connection with the completion of the Business Combination, the Company amended and restated its certificate of incorporation, effective as of the Closing Date, pursuant to the Second A&R Certificate of Incorporation”
Cycurion, Inc. underwent a change of control involving Western Acquisition Ventures Corp. (closed 2025-02-14).
“On February 14, 2025 (the “Closing Date”), the parties completed the Business Combination.”
Kevin E. O’Brien was appointed as Director at Cycurion, Inc..
“Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.”
Reginald S. Bailey, Sr. was appointed as Director at Cycurion, Inc..
“Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.”
Peter Ginsberg was appointed as Director at Cycurion, Inc..
“Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.”
L. Kevin Kelly was appointed as Director at Cycurion, Inc..
“Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.”
Emmit McHenry was appointed as Director at Cycurion, Inc..
“Emmit McHenry, L. Kevin Kelly, Peter Ginsberg, Reginald S. Bailey, Sr., and Kevin E. O’Brien were appointed as directors of the Company.”
Cycurion, Inc. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).
“January 23, 2025 and (iii) a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Since the Company failed to complete its initial business combination by January 11, 2025, the Staff concluded that the Company did not comply with Rule IM-5101-2 and that the Company’s securities a”
Cycurion, Inc. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).
“January 16, 2025, Western Acquisition Ventures Corp. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that, pursuant to Nasdaq Listing Rule IM-510”
Cycurion, Inc.: The company filed a charter amendment extending the deadline to consummate a business combination from January 11, 2025 to April 11, 2025 (effective 2025-01-08).
“The Charter Amendment extends the date by which the Company has to consummate a business combination from January 11, 2025 to April 11, 2025.”
Cycurion, Inc. amended Amended and Restated Business Combination Agreement with Western Acquisition Ventures Corp. and Western Acquisition Merger Inc. valued at Amendment to the Business Combination Agreement to amend economic terms at closing and extend termin (effective 2024-04-26).
“On April 26, 2024, the Parties amended and restated the Business Combination Agreement (the “ Amended and Restated Business Combination Agreement ”) to amend, among other things, certain economic terms at the closing of the Business Combination and the Termination Date to complete the Business Combination, defined in the Section 1.1 of the Business Combination Agreement, from December 31, 2023 to December 31, 2024.”
Cycurion, Inc.: Extended the deadline to consummate a business combination from April 11, 2024 to July 11, 2024 (effective 2024-04-10).
“The Charter Amendment extends the date by which the Company has to consummate a business combination from April 11, 2024 to July 11, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.